Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (131)

2024

  1. Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial

    The Lancet Respiratory Medicine, Vol. 12, Núm. 3, pp. 195-206

  2. Infectious complications following major heart surgery from the day of the surgery to hospital discharge

    BMC Infectious Diseases, Vol. 24, Núm. 1

  3. Vitamin D and Pulmonary Arterial Hypertension

    Archivos de Bronconeumologia

2023

  1. Association between use of enhanced recovery after surgery protocols and postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study

    Cirugia Espanola, Vol. 101, Núm. 10, pp. 665-677

  2. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  3. Dietary Supplementation with a Cocoa–Carob Blend Modulates Gut Microbiota and Prevents Intestinal Oxidative Stress and Barrier Dysfunction in Zucker Diabetic Rats

    Antioxidants, Vol. 12, Núm. 8

  4. Glycolysis in pulmonary arterial hypertension and metabolic reprogramming

    Glycolysis: Tissue-Specific Metabolic Regulation in Physio-pathological Conditions (Elsevier), pp. 267-296

  5. Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation

    Pharmacological Research, Vol. 194

  6. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  7. Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice

    British Journal of Pharmacology, Vol. 180, Núm. 18, pp. 2361-2376

  8. Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart

    Journal of Physiology, Vol. 601, Núm. 17, pp. 3717-3737

  9. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities

    PLoS pathogens, Vol. 19, Núm. 1, pp. e1011063

  10. Publisher Correction: Early corticosteroids are associated with lower mortality in critically ill patients with COVID‑19: a cohort study (Critical Care, (2021), 25, 1, (2), 10.1186/s13054-020-03422-3)

    Critical Care

  11. Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function

    Pharmacological Research, Vol. 189

  12. Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension

    Frontiers in Pharmacology, Vol. 14

  13. Targeting IL-11 system as a treatment of pulmonary arterial hypertension

    Pharmacological research, Vol. 197, pp. 106985

  14. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

  15. Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

2022

  1. Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension

    Molecular Therapy - Nucleic Acids

  2. Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: The EuroPOWER international observational study

    Journal of Clinical Anesthesia, Vol. 80